The University of Chicago Header Logo

Seiko Diane Yamada

Concepts (380)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
34
2022
744
2.880
Why?
Endometrial Neoplasms
16
2018
193
1.700
Why?
Peritoneal Neoplasms
11
2016
177
1.390
Why?
Fallopian Tube Neoplasms
7
2016
35
0.990
Why?
Uterine Neoplasms
5
2019
227
0.860
Why?
Genital Neoplasms, Female
4
2016
107
0.750
Why?
MAP Kinase Kinase 4
5
2012
67
0.740
Why?
Antineoplastic Combined Chemotherapy Protocols
11
2016
2438
0.720
Why?
Neoplasms, Glandular and Epithelial
3
2017
74
0.680
Why?
Intestinal Obstruction
1
2019
87
0.650
Why?
Neoplasm Recurrence, Local
10
2019
1313
0.550
Why?
Female
66
2022
44566
0.460
Why?
Neoplasm Metastasis
12
2019
1056
0.450
Why?
Omentum
7
2018
71
0.440
Why?
Carcinosarcoma
1
2012
20
0.430
Why?
Antineoplastic Agents, Hormonal
2
2012
150
0.410
Why?
Tamoxifen
1
2012
168
0.400
Why?
Carcinoma, Endometrioid
3
2018
43
0.400
Why?
MAP Kinase Signaling System
5
2018
193
0.390
Why?
Aged, 80 and over
22
2022
6511
0.380
Why?
Cystadenocarcinoma, Serous
4
2016
45
0.370
Why?
Middle Aged
38
2022
25027
0.360
Why?
Aged
35
2022
18407
0.350
Why?
Uterine Cervical Neoplasms
7
2012
275
0.340
Why?
Biomarkers, Tumor
5
2014
1464
0.340
Why?
Ovariectomy
4
2014
81
0.330
Why?
Cancer-Associated Fibroblasts
2
2019
36
0.330
Why?
Posterior Leukoencephalopathy Syndrome
1
2008
12
0.320
Why?
Epithelial Cells
4
2017
670
0.320
Why?
Humans
68
2022
86656
0.320
Why?
Mitogen-Activated Protein Kinase Kinases
2
2012
101
0.320
Why?
Proteomics
2
2019
212
0.300
Why?
Receptor, Platelet-Derived Growth Factor alpha
1
2006
11
0.290
Why?
Adult
32
2022
25648
0.290
Why?
MAP Kinase Kinase 6
1
2006
12
0.280
Why?
Fallopian Tubes
2
2017
41
0.280
Why?
Chylous Ascites
1
2005
9
0.270
Why?
Retroperitoneal Neoplasms
1
2005
43
0.260
Why?
Sarcoma
2
2006
215
0.260
Why?
Teratoma
1
2005
50
0.260
Why?
Hyperlipidemias
2
2016
95
0.260
Why?
Tumor Cells, Cultured
8
2016
1041
0.250
Why?
Disease-Free Survival
9
2015
1204
0.240
Why?
Adipocytes
2
2018
155
0.240
Why?
Cisplatin
9
2016
612
0.230
Why?
Carcinoma, Small Cell
1
2004
134
0.230
Why?
Paclitaxel
5
2012
460
0.230
Why?
Adenocarcinoma, Clear Cell
6
2012
62
0.220
Why?
Retrospective Studies
13
2019
8476
0.220
Why?
Neoplasm Grading
2
2015
357
0.210
Why?
Genes, Tumor Suppressor
1
2002
157
0.210
Why?
Radiotherapy, Conformal
4
2003
83
0.210
Why?
Mice, Nude
9
2018
789
0.200
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2016
378
0.200
Why?
Neoplasm Invasiveness
10
2014
552
0.190
Why?
Cancer Survivors
1
2022
85
0.190
Why?
Cell Line, Tumor
8
2019
2427
0.190
Why?
Sexual Behavior
2
2015
302
0.180
Why?
Hysterectomy
8
2018
146
0.180
Why?
Glycolysis
2
2018
129
0.180
Why?
Nicotinamide N-Methyltransferase
1
2019
6
0.170
Why?
Infusions, Intravenous
5
2012
429
0.170
Why?
Antibodies, Monoclonal, Humanized
3
2013
931
0.170
Why?
Neoplasm Staging
12
2012
1938
0.170
Why?
Mice
15
2018
11439
0.170
Why?
RNA, Small Interfering
3
2016
547
0.160
Why?
Gene Expression Regulation, Neoplastic
5
2018
1197
0.160
Why?
Prognosis
8
2019
3681
0.160
Why?
DNA-Binding Proteins
3
2018
1214
0.160
Why?
Cohort Studies
5
2017
2765
0.160
Why?
Glycogen
1
2018
59
0.160
Why?
CD36 Antigens
1
2018
13
0.160
Why?
DNA Repair Enzymes
1
2018
52
0.160
Why?
Coculture Techniques
5
2018
164
0.150
Why?
Drug Resistance, Neoplasm
2
2018
592
0.150
Why?
Proto-Oncogene Proteins c-met
2
2011
199
0.150
Why?
Combined Modality Therapy
7
2006
1686
0.150
Why?
Immunohistochemistry
5
2018
1759
0.150
Why?
Carboplatin
3
2012
286
0.140
Why?
Antigens, Neoplasm
1
2018
325
0.140
Why?
Cell Adhesion
7
2014
422
0.140
Why?
Radiotherapy, Adjuvant
5
2004
292
0.140
Why?
Caryophyllaceae
1
2005
2
0.130
Why?
Basidiomycota
1
2005
10
0.130
Why?
Cadherins
2
2008
153
0.130
Why?
Treatment Outcome
10
2019
7982
0.130
Why?
Siderophores
1
2005
22
0.130
Why?
BRCA1 Protein
1
2017
200
0.130
Why?
Nanomedicine
1
2015
14
0.130
Why?
Animals
17
2018
26706
0.130
Why?
Venous Thromboembolism
1
2017
152
0.130
Why?
Neoplasms, Unknown Primary
1
2014
15
0.130
Why?
Polymers
1
2016
202
0.130
Why?
Drug Delivery Systems
1
2016
178
0.120
Why?
Nanoparticles
1
2016
157
0.120
Why?
Pelvic Neoplasms
3
2004
45
0.120
Why?
Vinblastine
2
2004
108
0.120
Why?
Fibronectins
1
2014
98
0.120
Why?
Population Surveillance
1
2015
219
0.120
Why?
Diffusion Magnetic Resonance Imaging
1
2016
294
0.120
Why?
Sex Cord-Gonadal Stromal Tumors
1
2013
18
0.120
Why?
Piperazines
1
2005
272
0.120
Why?
Sequence Analysis, DNA
1
2016
853
0.110
Why?
Neoplasm Transplantation
3
2011
392
0.110
Why?
Infusions, Parenteral
2
2011
51
0.110
Why?
Receptor, IGF Type 1
1
2012
44
0.110
Why?
Adenocarcinoma
5
2004
1169
0.110
Why?
Tissue Array Analysis
1
2012
124
0.110
Why?
Ustilago
1
2002
5
0.110
Why?
Survival Analysis
3
2012
1540
0.100
Why?
Ascites
1
2011
56
0.100
Why?
Cystadenocarcinoma, Papillary
4
2004
9
0.100
Why?
Benzimidazoles
1
2012
140
0.100
Why?
Disease Progression
4
2019
1534
0.100
Why?
Sirolimus
1
2012
170
0.100
Why?
Anoikis
1
2011
7
0.100
Why?
Follow-Up Studies
5
2012
3639
0.100
Why?
Angiogenesis Inhibitors
1
2013
311
0.100
Why?
TOR Serine-Threonine Kinases
1
2012
182
0.100
Why?
Kaplan-Meier Estimate
4
2018
861
0.100
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2011
84
0.100
Why?
Receptors, Urokinase Plasminogen Activator
1
2010
21
0.100
Why?
Anilides
1
2011
47
0.100
Why?
DNA Transposable Elements
1
2002
169
0.100
Why?
Extracellular Matrix
2
2014
235
0.100
Why?
Viral Tail Proteins
1
2010
2
0.090
Why?
Quinolines
1
2011
95
0.090
Why?
Bacteriophage mu
1
2010
17
0.090
Why?
Hepatocyte Growth Factor
1
2010
84
0.090
Why?
Xenograft Model Antitumor Assays
4
2016
458
0.090
Why?
Prospective Studies
2
2016
4212
0.090
Why?
Metformin
1
2012
128
0.090
Why?
Chemoradiotherapy
1
2012
301
0.090
Why?
Integrin alphaVbeta3
1
2009
17
0.090
Why?
Recombinant Fusion Proteins
1
2011
560
0.090
Why?
Vascular Endothelial Growth Factor A
1
2011
411
0.090
Why?
Receptor Protein-Tyrosine Kinases
1
2010
153
0.090
Why?
Needs Assessment
1
2010
154
0.090
Why?
Mutation
6
2017
3977
0.090
Why?
Dual Specificity Phosphatase 1
1
2009
17
0.090
Why?
Antineoplastic Agents
5
2018
2360
0.090
Why?
Breast Neoplasms
2
2014
2904
0.080
Why?
Hypoglycemic Agents
1
2012
378
0.080
Why?
Tissue Culture Techniques
1
2009
80
0.080
Why?
Integrin alpha5
1
2008
6
0.080
Why?
Gene Expression Profiling
2
2012
1387
0.080
Why?
Mitogen-Activated Protein Kinase 8
1
2008
24
0.080
Why?
Fibroblasts
2
2009
731
0.080
Why?
Chemotherapy, Adjuvant
4
2003
468
0.080
Why?
Recombinant Proteins
1
2010
1018
0.080
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
74
0.080
Why?
Coagulation Protein Disorders
1
2007
2
0.080
Why?
Vaginitis
1
2007
3
0.080
Why?
Immediate-Early Proteins
1
2009
164
0.080
Why?
Brachytherapy
5
2012
119
0.080
Why?
Plasminogen
1
2007
41
0.080
Why?
Dexamethasone
1
2009
326
0.080
Why?
Cell Proliferation
4
2018
1596
0.080
Why?
Bevacizumab
3
2013
281
0.080
Why?
Apoptosis
4
2010
1689
0.070
Why?
Escherichia coli
1
2010
598
0.070
Why?
Neoplasms
2
2015
2898
0.070
Why?
Receptor, Platelet-Derived Growth Factor beta
1
2006
28
0.070
Why?
Glucocorticoids
1
2009
350
0.070
Why?
Proto-Oncogene Proteins c-kit
1
2006
80
0.070
Why?
Diabetes Mellitus, Type 2
2
2012
1374
0.070
Why?
MAP Kinase Kinase 7
1
2006
21
0.070
Why?
Cells, Cultured
3
2019
2839
0.070
Why?
Hematologic Diseases
1
2006
79
0.070
Why?
Doxorubicin
2
2004
295
0.070
Why?
Basic-Leucine Zipper Transcription Factors
1
2006
41
0.070
Why?
Cell Division
2
2008
696
0.070
Why?
Mice, SCID
1
2006
254
0.070
Why?
Clitoris
1
2005
4
0.070
Why?
Carcinoma
1
2009
436
0.060
Why?
Carcinoma, Squamous Cell
1
2012
1077
0.060
Why?
Tumor Suppressor Proteins
2
2008
279
0.060
Why?
Down-Regulation
2
2006
508
0.060
Why?
Sexual Dysfunctions, Psychological
1
2005
32
0.060
Why?
Radiotherapy, Intensity-Modulated
1
2006
173
0.060
Why?
Up-Regulation
3
2018
717
0.060
Why?
Chicago
4
2016
1380
0.060
Why?
Transplantation, Heterologous
1
2006
363
0.060
Why?
Bone Marrow
1
2006
435
0.060
Why?
Transcription Factors
3
2006
1580
0.060
Why?
Sexual Dysfunction, Physiological
1
2005
66
0.060
Why?
Physical Therapy Modalities
1
2005
83
0.060
Why?
DNA Methylation
2
2019
630
0.060
Why?
Bleomycin
1
2004
98
0.060
Why?
Blotting, Western
3
2012
786
0.060
Why?
Cross-Sectional Studies
2
2022
1618
0.060
Why?
Etoposide
1
2004
196
0.060
Why?
Cell Cycle
3
2011
503
0.060
Why?
Cyclophosphamide
1
2004
299
0.060
Why?
Saccharomyces cerevisiae Proteins
1
2006
276
0.060
Why?
Blood
1
2002
69
0.050
Why?
Rhabdomyosarcoma, Embryonal
1
2002
6
0.050
Why?
Oxidative Stress
1
2006
448
0.050
Why?
Electronics
1
2022
15
0.050
Why?
Repressor Proteins
1
2006
405
0.050
Why?
Young Adult
4
2018
5977
0.050
Why?
CA-125 Antigen
2
2014
22
0.050
Why?
alpha-Fetoproteins
1
2001
45
0.050
Why?
Cell Movement
2
2018
762
0.050
Why?
Patient Reported Outcome Measures
1
2022
164
0.050
Why?
Enzyme Activation
1
2002
693
0.050
Why?
Signal Transduction
2
2014
3267
0.050
Why?
Lymphatic Metastasis
4
2003
486
0.050
Why?
Vaginal Neoplasms
3
2007
83
0.040
Why?
Cell Cycle Proteins
1
2002
388
0.040
Why?
Quality of Life
2
2022
1587
0.040
Why?
Time Factors
4
2012
5215
0.040
Why?
S-Adenosylhomocysteine
1
2019
9
0.040
Why?
Imaging, Three-Dimensional
1
2003
581
0.040
Why?
S-Adenosylmethionine
1
2019
15
0.040
Why?
Feasibility Studies
2
2011
751
0.040
Why?
RNA, Messenger
3
2012
1988
0.040
Why?
Radiotherapy Dosage
3
2006
468
0.040
Why?
Membrane Proteins
1
2006
1201
0.040
Why?
Niacinamide
1
2019
116
0.040
Why?
Cell Death
2
2011
257
0.040
Why?
Phosphoprotein Phosphatases
1
2018
57
0.040
Why?
Survival Rate
1
2002
1864
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2012
881
0.040
Why?
Curettage
1
2018
12
0.040
Why?
MutL Protein Homolog 1
1
2018
33
0.040
Why?
Mismatch Repair Endonuclease PMS2
1
2018
23
0.040
Why?
MutS Homolog 2 Protein
1
2018
30
0.040
Why?
Life Tables
3
2003
48
0.040
Why?
DNA Mismatch Repair
1
2018
52
0.040
Why?
Integrin alpha5beta1
2
2008
13
0.040
Why?
Radiation Dosage
2
2012
225
0.040
Why?
Maximum Tolerated Dose
2
2011
270
0.040
Why?
Cell Growth Processes
2
2008
83
0.040
Why?
Cell Culture Techniques
2
2009
188
0.040
Why?
Cyclooxygenase 2 Inhibitors
1
2017
33
0.040
Why?
Dose-Response Relationship, Drug
2
2011
1960
0.040
Why?
Histones
1
2019
311
0.040
Why?
Radiotherapy Planning, Computer-Assisted
3
2003
176
0.040
Why?
Chemoprevention
1
2017
92
0.040
Why?
Drug Administration Schedule
2
2011
915
0.040
Why?
Disease Models, Animal
2
2015
2243
0.040
Why?
Genomic Instability
1
2016
79
0.030
Why?
Endosomes
1
2016
75
0.030
Why?
Aspirin
1
2017
155
0.030
Why?
Tissue Distribution
1
2016
292
0.030
Why?
Mice, Inbred BALB C
1
2018
1059
0.030
Why?
Gene Silencing
1
2016
173
0.030
Why?
Nanostructures
1
2016
77
0.030
Why?
Carbon Dioxide
1
2016
188
0.030
Why?
Crosses, Genetic
1
2005
171
0.030
Why?
Tumor Microenvironment
1
2018
418
0.030
Why?
Plant Diseases
1
2005
75
0.030
Why?
Lovastatin
1
2014
29
0.030
Why?
Sexuality
1
2015
40
0.030
Why?
Amino Acid Sequence
1
2018
2065
0.030
Why?
Integrins
1
2014
76
0.030
Why?
Biopsy
1
2018
1163
0.030
Why?
Transforming Growth Factor beta1
1
2014
87
0.030
Why?
Inhibins
1
2013
37
0.030
Why?
Likelihood Functions
1
2014
251
0.030
Why?
Genes, BRCA2
1
2014
160
0.030
Why?
Carcinoma, Adenosquamous
2
2004
12
0.030
Why?
Genes, BRCA1
1
2014
192
0.030
Why?
Self Report
1
2015
288
0.030
Why?
Immunotherapy
1
2018
631
0.030
Why?
Phenotype
1
2019
2389
0.030
Why?
Injections, Intraperitoneal
1
2012
102
0.030
Why?
Robotic Surgical Procedures
1
2017
267
0.030
Why?
Tumor Stem Cell Assay
1
2012
35
0.030
Why?
Nuclear Proteins
1
1996
705
0.030
Why?
Taxoids
1
2012
129
0.030
Why?
Referral and Consultation
1
2015
328
0.030
Why?
ras Proteins
1
2012
128
0.030
Why?
Proto-Oncogene Proteins p21(ras)
1
2012
154
0.030
Why?
Fatty Acid-Binding Proteins
1
2011
26
0.030
Why?
Mice, Transgenic
2
2011
1557
0.030
Why?
Proto-Oncogene Proteins B-raf
1
2012
138
0.030
Why?
Receptors, Vascular Endothelial Growth Factor
1
2011
70
0.030
Why?
Immunoenzyme Techniques
1
2012
303
0.030
Why?
Injections, Intravenous
1
2011
242
0.030
Why?
Meiosis
1
2002
80
0.020
Why?
Phylogeny
1
2016
1137
0.020
Why?
Bone Neoplasms
2
2004
321
0.020
Why?
Logistic Models
1
2015
1185
0.020
Why?
Genomics
1
2016
720
0.020
Why?
Real-Time Polymerase Chain Reaction
1
2012
276
0.020
Why?
Microarray Analysis
1
2010
96
0.020
Why?
Models, Biological
2
2008
1752
0.020
Why?
Glycoside Hydrolases
1
2010
17
0.020
Why?
Lipid Metabolism
1
2011
197
0.020
Why?
Adolescent
2
2015
8988
0.020
Why?
Tumor Burden
1
2011
290
0.020
Why?
Clinical Trials as Topic
1
2015
1169
0.020
Why?
Multivariate Analysis
1
2012
999
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2012
691
0.020
Why?
Administration, Oral
1
2011
683
0.020
Why?
Patient Safety
1
2011
211
0.020
Why?
Proto-Oncogene Proteins
1
2012
645
0.020
Why?
Survivors
1
2010
227
0.020
Why?
Placebos
1
2009
218
0.020
Why?
Staining and Labeling
1
2009
165
0.020
Why?
Hemagglutinins
1
2008
19
0.020
Why?
Cattle
1
2009
376
0.020
Why?
Protein Structure, Tertiary
1
2010
738
0.020
Why?
Phosphorylation
1
2010
1106
0.020
Why?
p38 Mitogen-Activated Protein Kinases
1
2008
125
0.020
Why?
Procollagen-Proline Dioxygenase
1
2007
10
0.020
Why?
Microscopy, Phase-Contrast
1
2007
31
0.020
Why?
Keratins
1
2007
63
0.020
Why?
Vimentin
1
2007
44
0.020
Why?
Carcinoma, Papillary
1
2009
158
0.020
Why?
Transgenes
1
2008
181
0.020
Why?
Double-Blind Method
1
2011
1824
0.020
Why?
Postoperative Complications
1
2017
2204
0.020
Why?
Protein Kinase Inhibitors
1
2011
589
0.020
Why?
Femur Head
1
2006
8
0.020
Why?
Lumbosacral Region
1
2006
25
0.020
Why?
Ilium
1
2006
18
0.020
Why?
Leukopenia
1
2006
65
0.020
Why?
Transfection
1
2008
898
0.020
Why?
Sacrum
1
2006
40
0.020
Why?
Peroxidases
1
2006
34
0.020
Why?
Homeostasis
1
2008
410
0.020
Why?
Delivery of Health Care
1
2010
426
0.020
Why?
Radiation-Sensitizing Agents
1
2006
95
0.020
Why?
beta Catenin
1
2007
255
0.020
Why?
Endothelial Cells
1
2009
443
0.020
Why?
Genetic Predisposition to Disease
1
2014
2272
0.020
Why?
Neutropenia
1
2006
215
0.020
Why?
Orgasm
1
2005
9
0.020
Why?
Suction
1
2005
35
0.020
Why?
Anemia
1
2006
128
0.020
Why?
Least-Squares Analysis
1
2005
48
0.020
Why?
Thrombocytopenia
1
2006
183
0.020
Why?
Cell Survival
1
2007
971
0.020
Why?
Antibodies, Monoclonal
1
2010
1380
0.020
Why?
Endoplasmic Reticulum
1
2006
250
0.020
Why?
Analysis of Variance
1
2006
911
0.010
Why?
Risk Factors
1
2014
5416
0.010
Why?
Protein Folding
1
2006
282
0.010
Why?
Bone Marrow Diseases
1
2003
40
0.010
Why?
Cystadenocarcinoma
1
2003
12
0.010
Why?
Diagnosis, Differential
1
2007
1564
0.010
Why?
Abdominal Neoplasms
1
2003
39
0.010
Why?
Biomarkers
1
2009
1722
0.010
Why?
COP9 Signalosome Complex
1
2002
1
0.010
Why?
Cyclin-Dependent Kinase Inhibitor p27
1
2002
36
0.010
Why?
Palatine Tonsil
1
2002
30
0.010
Why?
Rectum
1
2003
146
0.010
Why?
Dose-Response Relationship, Radiation
1
2002
188
0.010
Why?
Neoplasms, Multiple Primary
1
2003
100
0.010
Why?
Saccharomyces cerevisiae
1
2006
434
0.010
Why?
Treatment Failure
1
2003
286
0.010
Why?
Radiation Injuries
1
2003
156
0.010
Why?
Peptide Hydrolases
1
2002
100
0.010
Why?
Pilot Projects
1
2005
840
0.010
Why?
Proportional Hazards Models
1
2004
860
0.010
Why?
Urinary Bladder
1
2003
245
0.010
Why?
Intestine, Small
1
2003
302
0.010
Why?
Lung Neoplasms
2
2004
2262
0.010
Why?
Pelvis
1
2001
94
0.010
Why?
Intracellular Signaling Peptides and Proteins
1
2002
382
0.010
Why?
Radiography
1
2002
808
0.010
Why?
Risk
1
2001
674
0.010
Why?
Hepatocyte Nuclear Factor 1
1
1996
30
0.010
Why?
Hepatocyte Nuclear Factor 1-beta
1
1996
34
0.010
Why?
Chromosomes, Human, Pair 12
1
1996
65
0.010
Why?
Restriction Mapping
1
1996
157
0.010
Why?
Hepatocyte Nuclear Factor 1-alpha
1
1996
80
0.010
Why?
Cell Differentiation
1
2002
1471
0.010
Why?
Infant
1
2002
3048
0.010
Why?
Child, Preschool
1
2002
3612
0.010
Why?
Pedigree
1
1996
966
0.010
Why?
Tomography, X-Ray Computed
1
2002
2585
0.010
Why?
Molecular Sequence Data
1
1996
3035
0.010
Why?
Liver
1
1996
1229
0.010
Why?
Child
1
2002
6933
0.010
Why?
Rats
1
1996
4004
0.010
Why?
Male
2
2002
40995
0.000
Why?
Yamada's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (380)
Explore
_
Co-Authors (47)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_